The Ministry of Health has granted the permission for circulation of the vaccine.
POLYVAC said that in June, 2017, there will be 2.5 million dozes of rubella-measles vaccine for the National Expanded Immunization Program to replace India-made vaccines which are used at present.
Center director Nguyen Dang Hien said the Ministry’s permission for circulation marked a success in researches for vaccine as per the new technology; the vaccine is produced en mass to meet the demand.
The vaccine is a combination of the two elements to prevent rubella and measles. Not only kids but also pregnant women to prevent deformity can be injected Vietnamese-made vaccine.
Vietnam has been the fourth Asian countries to successfully make the vaccine. The production of the vaccine helps the health sector to take the initiative in preventing the two diseases.
POLYVAC said that in June, 2017, there will be 2.5 million dozes of rubella-measles vaccine for the National Expanded Immunization Program to replace India-made vaccines which are used at present.
Center director Nguyen Dang Hien said the Ministry’s permission for circulation marked a success in researches for vaccine as per the new technology; the vaccine is produced en mass to meet the demand.
The vaccine is a combination of the two elements to prevent rubella and measles. Not only kids but also pregnant women to prevent deformity can be injected Vietnamese-made vaccine.
Vietnam has been the fourth Asian countries to successfully make the vaccine. The production of the vaccine helps the health sector to take the initiative in preventing the two diseases.
Moreover, Vietnamese-made vaccine helps avoid the shortage of vaccine and reduce the state budget’s because the price of domestically-made vaccine is half of their foreign kind.
